2022 Q4 Form 10-K Financial Statement
#000121390023025429 Filed on March 31, 2023
Income Statement
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
Revenue | $0.00 | $6.125M | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $218.8K | $1.031M | $94.56K |
YoY Change | 131.35% | 108.63% | -27.26% |
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $89.29K | $1.062M | $144.6K |
YoY Change | -38.25% | 52.93% | -19.67% |
Operating Profit | -$1.062M | ||
YoY Change | -100.61% | ||
Interest Expense | $669.5K | $10.55M | $541.0K |
YoY Change | 23.74% | 84.16% | -280.34% |
% of Operating Profit | |||
Other Income/Expense, Net | -$5.274M | -$680.7K | $0.00 |
YoY Change | -100.0% | ||
Pretax Income | -$4.694M | $8.808M | $396.5K |
YoY Change | -1284.07% | 74.94% | -146.64% |
Income Tax | $58.03K | $185.2K | $0.00 |
% Of Pretax Income | 2.1% | 0.0% | |
Net Earnings | -$4.752M | $8.622M | $396.5K |
YoY Change | -1298.71% | 71.27% | -146.64% |
Net Earnings / Revenue | 140.77% | ||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$0.77 | $0.48 | $18.12K |
COMMON SHARES | |||
Basic Shares Outstanding | 2.244K shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.149M | $1.149M | $1.513M |
YoY Change | -24.02% | -24.02% | -24.38% |
Cash & Equivalents | $1.149M | $1.149M | $1.512M |
Short-Term Investments | |||
Other Short-Term Assets | $176.5K | $176.5K | $103.1K |
YoY Change | 71.19% | 71.19% | -65.64% |
Inventory | |||
Prepaid Expenses | $176.5K | $103.1K | |
Receivables | |||
Other Receivables | $42.42K | ||
Total Short-Term Assets | $1.368M | $1.368M | $1.616M |
YoY Change | -15.32% | -15.32% | -29.76% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $0.00 | $0.00 | $175.1M |
YoY Change | -100.0% | -100.0% | 0.06% |
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | $175.1M |
YoY Change | -100.0% | -100.0% | 0.06% |
TOTAL ASSETS | |||
Total Short-Term Assets | $1.368M | $1.368M | $1.616M |
Total Long-Term Assets | $0.00 | $0.00 | $175.1M |
Total Assets | $1.368M | $1.368M | $176.7M |
YoY Change | -99.23% | -99.23% | -0.32% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $459.6K | $459.6K | $256.2K |
YoY Change | 79.39% | 79.39% | 28.1% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $489.8K | $489.8K | $256.2K |
YoY Change | 91.17% | 91.17% | 28.1% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $149.0K | $149.0K | $15.66M |
YoY Change | -99.05% | -99.05% | -26.47% |
Total Long-Term Liabilities | $149.0K | $149.0K | $15.66M |
YoY Change | -99.05% | -99.05% | -26.47% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $489.8K | $489.8K | $256.2K |
Total Long-Term Liabilities | $149.0K | $149.0K | $15.66M |
Total Liabilities | $638.8K | $638.8K | $15.92M |
YoY Change | -95.99% | -95.99% | -25.96% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$303.7K | -$14.19M | |
YoY Change | -97.86% | ||
Common Stock | $300.00 | $0.00 | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $729.3K | $729.3K | -$14.19M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.368M | $1.368M | $176.7M |
YoY Change | -99.23% | -99.23% | -0.32% |
Cashflow Statement
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$4.752M | $8.622M | $396.5K |
YoY Change | -1298.71% | 71.27% | -146.64% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$379.5K | -$1.129M | -$58.19K |
YoY Change | 552.23% | 129.18% | -80.6% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $20.72M | $176.3M | $0.00 |
YoY Change | |||
Cash From Investing Activities | $20.72M | $176.3M | $0.00 |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | -$175.5M | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -20.63M | -$175.5M | 0.000 |
YoY Change | -100.0% | ||
NET CHANGE | |||
Cash From Operating Activities | -379.5K | -$1.129M | -58.19K |
Cash From Investing Activities | 20.72M | $176.3M | 0.000 |
Cash From Financing Activities | -20.63M | -$175.5M | 0.000 |
Net Change In Cash | -287.1K | -$363.3K | -58.19K |
YoY Change | 393.4% | -93.07% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$379.5K | -$1.129M | -$58.19K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021 | pmvc |
Adjustment Of Forgiveness Of Deferred Underwriting Payable
AdjustmentOfForgivenessOfDeferredUnderwritingPayable
|
usd | |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
001-39534 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
PMV CONSUMER ACQUISITION CORP. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
84-5174573 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
249 Royal Palm Way | |
CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 503 | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Palm Beach | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
33480 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
(561) | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
318-3766 | |
CY2022 | dei |
Security12b Title
Security12bTitle
|
Class A common stock, $0.0001 per share | |
CY2022 | dei |
Trading Symbol
TradingSymbol
|
PMVC | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2022 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
154050000 | usd |
CY2022 | dei |
Auditor Name
AuditorName
|
WithumSmith+Brown, PC | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
New York, New York | |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
100 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1149157 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1512496 | usd |
CY2022Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
42424 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
176463 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
103084 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1368044 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1615580 | usd |
CY2021Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
175109162 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
1368044 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
176724742 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
459591 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
256203 | usd |
CY2022Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
30192 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
489783 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
256203 | usd |
CY2021Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
6125000 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
149000 | usd |
CY2021Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
9537845 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
638783 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
15919048 | usd |
CY2021Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
|
175000000 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
300 | usd |
CY2022Q4 | pmvc |
Common Stock Value One
CommonStockValueOne
|
117 | usd |
CY2021Q4 | pmvc |
Common Stock Value One
CommonStockValueOne
|
437 | usd |
CY2022Q4 | pmvc |
Common Stock Value Two
CommonStockValueTwo
|
20 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1032490 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
66 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-303666 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-14194809 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
729261 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14194306 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1368044 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
176724742 | usd |
CY2022 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1031318 | usd |
CY2021 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
494342 | usd |
CY2022 | pmvc |
Franchise Tax Expense
FranchiseTaxExpense
|
30526 | usd |
CY2021 | pmvc |
Franchise Tax Expense
FranchiseTaxExpense
|
200000 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1061844 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-694342 | usd |
CY2022 | us-gaap |
Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
|
1161232 | usd |
CY2021 | us-gaap |
Interest Income Securities Other Us Government
InterestIncomeSecuritiesOtherUSGovernment
|
68652 | usd |
CY2022 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
9388845 | usd |
CY2021 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
5660155 | usd |
CY2022 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
-990000 | usd |
CY2022 | pmvc |
Forgiveness Of Deferred Underwriting Fee Payable
ForgivenessOfDeferredUnderwritingFeePayable
|
309312 | usd |
CY2022 | us-gaap |
Other Income
OtherIncome
|
9869389 | usd |
CY2021 | us-gaap |
Other Income
OtherIncome
|
5728807 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
8807545 | usd |
CY2021 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
5034465 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
185192 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8622353 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5034465 | usd |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
2244 | shares |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-19228771 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5034465 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-14194306 | usd |
CY2022 | pmvc |
Contribution Of Common Stock Founder Shares To Trust Account
ContributionOfCommonStockFounderSharesToTrustAccount
|
990000 | usd |
CY2022 | pmvc |
Common Stock Issued At Redemption
CommonStockIssuedAtRedemption
|
42424 | usd |
CY2022 | us-gaap |
Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
|
5268790 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8622353 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
729261 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
8622353 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5034465 | usd |
CY2022 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1161232 | usd |
CY2021 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
68652 | usd |
CY2022 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-9388845 | usd |
CY2021 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-5660155 | usd |
CY2022 | us-gaap |
Loss On Sale Of Investments
LossOnSaleOfInvestments
|
990000 | usd |
CY2022 | pmvc |
Adjustment Of Forgiveness Of Deferred Underwriting Payable
AdjustmentOfForgivenessOfDeferredUnderwritingPayable
|
309312 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
42424 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
73379 | usd |
CY2021 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-159432 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
30192 | usd |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
203388 | usd |
CY2021 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
42178 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1129259 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-492732 | usd |
CY2022 | pmvc |
Cash Withdrawn From Trust Account To Reimburse Expenses
CashWithdrawnFromTrustAccountToReimburseExpenses
|
723496 | usd |
CY2022 | pmvc |
Cash Withdrawn From Trust Account To Redeeming Investors
CashWithdrawnFromTrustAccountToRedeemingInvestors
|
175546898 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
176270394 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
-175546898 | usd |
CY2022 | pmvc |
Proceeds From Conversion Of Shares
ProceedsFromConversionOfShares
|
42424 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-175504474 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-363339 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-492732 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1512496 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2005228 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1149157 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1512496 | usd |
CY2022 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
155000 | usd |
CY2022 | pmvc |
Forgiveness Of Deferred Underwriting Fee Payable Allocated To Class A Common Stock
ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassACommonStock
|
5815688 | usd |
CY2022 | pmvc |
Contribution Of Class B Common Stock To The Trust Account
ContributionOfClassBCommonStockToTheTrustAccount
|
990000 | usd |
CY2022 | pmvc |
Conversion Of Class B Common Stock To Class A Common Stock
ConversionOfClassBCommonStockToClassACommonStock
|
300 | usd |
CY2022 | pmvc |
Conversion Of Class B Common Stock To Class C Common Stock
ConversionOfClassBCommonStockToClassCCommonStock
|
20 | usd |
CY2022 | us-gaap |
Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
|
9957390 | usd |
CY2022 | us-gaap |
Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
|
3500000 | usd |
CY2022 | us-gaap |
Other Underwriting Expense
OtherUnderwritingExpense
|
6125000 | usd |
CY2022Q4 | us-gaap |
Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
|
507390 | usd |
CY2022 | pmvc |
Offset Credit By Underwriters
OffsetCreditByUnderwriters
|
175000 | usd |
CY2022 | us-gaap |
Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
|
Following the closing of the Initial Public Offering on September 24, 2020, an amount of $175,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”) located in the United States, and was only invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-end investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below. | |
CY2022Q3 | pmvc |
Net Tangible Book Value
NetTangibleBookValue
|
5000001 | usd |
CY2022Q3 | us-gaap |
Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
|
200000 | shares |
CY2022Q3 | us-gaap |
Treasury Stock Preferred Shares
TreasuryStockPreferredShares
|
20000000 | shares |
CY2022Q3 | us-gaap |
Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
|
0.20 | pure |
CY2022 | pmvc |
Stockholders Holding Description
StockholdersHoldingDescription
|
At the Meeting, in connection with the extension, stockholders holding 15,453,391 shares of Class A common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, $154,874,303 (approximately $10.02 per share), which included $340,393 of interest earned on the Trust Account which was not previously used to pay the Company’s tax obligation, was removed from the Trust Account to pay such holders. Following these redemptions, the Company had 2,046,609 shares of Class A common stock outstanding and the aggregate amount remaining in the Trust Account at the time was $20,511,170. | |
CY2022Q4 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
2042409 | shares |
CY2022Q4 | pmvc |
Reduction Per Shares
ReductionPerShares
|
10.1 | usd |
CY2022Q4 | us-gaap |
Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
|
200000 | shares |
CY2022Q4 | us-gaap |
Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
|
42424 | usd |
CY2022Q4 | pmvc |
Redemption Description
RedemptionDescription
|
Following the redemption, the Company has outstanding 3,000,000 shares of Class A common stock, 1,175,000 shares of Class B common stock, 204,200 shares of Class C common stock, 8,750,000 public warrants and 6,150,000 private placement warrants, as well as approximately $1,149,157 of cash on hand available for working capital purposes. | |
CY2022Q3 | us-gaap |
Deferred Sales Commission
DeferredSalesCommission
|
4593750 | usd |
CY2022 | pmvc |
Underwriting Deferred Fee
UnderwritingDeferredFee
|
0.35 | |
CY2022Q3 | us-gaap |
Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
|
4593750 | usd |
CY2022Q4 | pmvc |
Underwriting Fee
UnderwritingFee
|
1531250 | usd |
CY2022 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
6125000 | usd |
CY2022 | pmvc |
Fee Payable
FeePayable
|
5815688 | usd |
CY2022 | pmvc |
Warrant Liabilities
WarrantLiabilities
|
309312 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b><i><span style="text-decoration:underline">Use of Estimates</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> | |
CY2021 | us-gaap |
Gross Profit
GrossProfit
|
175000000 | usd |
CY2021 | pmvc |
Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
|
-8837500 | usd |
CY2021 | pmvc |
Class A Shares Offering Costs
ClassASharesOfferingCosts
|
-9454542 | usd |
CY2021 | pmvc |
Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
|
18292042 | usd |
CY2021 | pmvc |
Class A Common Stock Subject To Possible Redemptionin Shares
ClassACommonStockSubjectToPossibleRedemptioninShares
|
175000000 | usd |
CY2022 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
-175546898 | usd |
CY2022 | pmvc |
Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
|
-5268790 | usd |
CY2022 | pmvc |
Waiver Of Class A Issuance Costs
WaiverOfClassAIssuanceCosts
|
5815688 | usd |
CY2020Q3 | pmvc |
Aggregate Offering Cost
AggregateOfferingCost
|
9957390 | usd |
CY2020Q3 | pmvc |
Payments For Underwriting Expenses
PaymentsForUnderwritingExpenses
|
3500000 | usd |
CY2020Q3 | pmvc |
Deferred Underwriting Fees
DeferredUnderwritingFees
|
6125000 | usd |
CY2020Q3 | pmvc |
Other Offering Costs
OtherOfferingCosts
|
507390 | usd |
CY2020Q3 | pmvc |
Underwriting Gross Proceeds
UnderwritingGrossProceeds
|
175000 | usd |
CY2022 | us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
0 | usd |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration:underline">Concentration of Credit Risk</span></i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2022 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
250000 | usd |
CY2022 | pmvc |
Sale Of Stock Number Of Share Issued In Transactions
SaleOfStockNumberOfShareIssuedInTransactions
|
17500000 | shares |
CY2022Q4 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10 | |
CY2020Q3 | us-gaap |
Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
|
the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B convertible common stock, resulting in an aggregate of 5,031,250 Founder Shares being outstanding, of which an aggregate of up to 656,250 shares were subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). | |
CY2022Q4 | pmvc |
Sponsor Owned Shares
SponsorOwnedShares
|
4175000 | shares |
CY2020Q3 | pmvc |
Administrative Fees
AdministrativeFees
|
10000 | usd |
CY2022 | us-gaap |
Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
|
120000 | usd |
CY2021 | us-gaap |
Investment Company Shareholder Service Fee Expense
InvestmentCompanyShareholderServiceFeeExpense
|
120000 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
|
272000 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities For Commissions Expense And Taxes
AccruedLiabilitiesForCommissionsExpenseAndTaxes
|
152000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
185192 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
0 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
|
753794 | usd |
CY2021 | us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
6125000 | usd |
CY2022Q3 | pmvc |
Excise Tax Percentage
ExciseTaxPercentage
|
0.01 | pure |
CY2022 | pmvc |
Excise Tax Percentage
ExciseTaxPercentage
|
0.01 | pure |
CY2022Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q3 | us-gaap |
Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
|
20000000 | shares |
CY2022 | pmvc |
Warrants For Redemption Description
WarrantsForRedemptionDescription
|
●in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption; ● if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to adjustment as described below) for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and ● If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants. | |
CY2022 | pmvc |
Total Outstanding Shares Percentage
TotalOutstandingSharesPercentage
|
1 | pure |
CY2022Q4 | us-gaap |
Excess Stock Shares Issued
ExcessStockSharesIssued
|
4379200 | shares |
CY2022Q4 | us-gaap |
Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
|
347876 | usd |
CY2021Q4 | us-gaap |
Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
|
110 | usd |
CY2021Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
158187 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
347876 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
158297 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
347876 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
158297 | usd |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
185192 | usd |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-164321 | usd |
CY2021 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-158297 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
164321 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
158297 | usd |
CY2022 | pmvc |
Ownership Interest Percentage
OwnershipInterestPercentage
|
0.50 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
|
0 | pure |
CY2022 | pmvc |
Effective Income Tax Rate Reconciliation Permanent Book Tax Differences
EffectiveIncomeTaxRateReconciliationPermanentBookTaxDifferences
|
0.208 | pure |
CY2021 | pmvc |
Effective Income Tax Rate Reconciliation Permanent Book Tax Differences
EffectiveIncomeTaxRateReconciliationPermanentBookTaxDifferences
|
0.274 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.019 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.064 | pure |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.021 | pure |
CY2021 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2022Q4 | pmvc |
Warrant Liability Public Warrants
WarrantLiabilityPublicWarrants
|
87500 | usd |
CY2022Q4 | pmvc |
Warrant Liability Private Placement Warrants
WarrantLiabilityPrivatePlacementWarrants
|
61500 | usd |
CY2021Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
175109162 | usd |
CY2021Q4 | pmvc |
Warrant Liability Public Warrants
WarrantLiabilityPublicWarrants
|
5600000 | usd |
CY2021Q4 | pmvc |
Warrant Liability Private Placement Warrants
WarrantLiabilityPrivatePlacementWarrants
|
3937845 | usd |
CY2022Q4 | us-gaap |
Fair Value Concentration Of Risk Cash And Cash Equivalents
FairValueConcentrationOfRiskCashAndCashEquivalents
|
0 | usd |
CY2021Q4 | us-gaap |
Fair Value Concentration Of Risk Cash And Cash Equivalents
FairValueConcentrationOfRiskCashAndCashEquivalents
|
195 | usd |
CY2022 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
723496 | usd |
CY2021Q4 | us-gaap |
Share Price
SharePrice
|
9.83 | |
CY2021Q4 | pmvc |
Fair Value Measurement Strike Price
FairValueMeasurementStrikePrice
|
11.5 | |
CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.1367 | pure |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0071 | pure |
CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure |
CY2021Q4 | pmvc |
Business Combination Step Acquisition Equity Interest In Acquiree Percentage1
BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage1
|
0.70 | pure |
CY2020Q4 | pmvc |
Fair Value Of Warrant Liabilities
FairValueOfWarrantLiabilities
|
15198000 | usd |
CY2021 | pmvc |
Change In Fair Value Recognized In Earnings
ChangeInFairValueRecognizedInEarnings
|
-5331155 | usd |
CY2021Q4 | pmvc |
Transfer Of Public Warrants To Level1
TransferOfPublicWarrantsToLevel1
|
-5929000 | usd |
CY2021Q4 | pmvc |
Fair Value Of Warrant Liabilities
FairValueOfWarrantLiabilities
|
3937845 | usd |
CY2022 | pmvc |
Change In Fair Value Recognized In Earnings
ChangeInFairValueRecognizedInEarnings
|
-3876345 | usd |
CY2022Q4 | pmvc |
Transfer Of Public Warrants To Level1
TransferOfPublicWarrantsToLevel1
|
-61500 | usd |
CY2022Q3 | pmvc |
Aggregate Share
AggregateShare
|
200000 | shares |
CY2022 | dei |
Security Exchange Name
SecurityExchangeName
|
NONE | |
CY2021Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
usd | |
CY2022Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
usd | |
CY2021Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
usd | |
CY2022Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
usd | |
CY2021Q4 | pmvc |
Common Stock Value Two
CommonStockValueTwo
|
usd | |
CY2022Q4 | pmvc |
Common Stock Value Three
CommonStockValueThree
|
usd | |
CY2021Q4 | pmvc |
Common Stock Value Three
CommonStockValueThree
|
usd | |
CY2021 | us-gaap |
Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
|
usd | |
CY2021 | pmvc |
Forgiveness Of Deferred Underwriting Fee Payable
ForgivenessOfDeferredUnderwritingFeePayable
|
usd | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
shares | |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
usd | |
CY2022 | pmvc |
Common Stock Founder Shares Converted
CommonStockFounderSharesConverted
|
usd | |
CY2021 | us-gaap |
Loss On Sale Of Investments
LossOnSaleOfInvestments
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
usd | |
CY2021 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
usd | |
CY2021 | pmvc |
Cash Withdrawn From Trust Account To Reimburse Expenses
CashWithdrawnFromTrustAccountToReimburseExpenses
|
usd | |
CY2021 | pmvc |
Cash Withdrawn From Trust Account To Redeeming Investors
CashWithdrawnFromTrustAccountToRedeemingInvestors
|
usd | |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | |
CY2021 | pmvc |
Proceeds From Conversion Of Shares
ProceedsFromConversionOfShares
|
usd | |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | |
CY2021 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
usd | |
CY2021 | pmvc |
Forgiveness Of Deferred Underwriting Fee Payable Allocated To Class A Common Stock
ForgivenessOfDeferredUnderwritingFeePayableAllocatedToClassACommonStock
|
usd | |
CY2021 | pmvc |
Contribution Of Class B Common Stock To The Trust Account
ContributionOfClassBCommonStockToTheTrustAccount
|
usd | |
CY2021 | pmvc |
Conversion Of Class B Common Stock To Class A Common Stock
ConversionOfClassBCommonStockToClassACommonStock
|
usd | |
CY2021 | pmvc |
Conversion Of Class B Common Stock To Class C Common Stock
ConversionOfClassBCommonStockToClassCCommonStock
|
usd | |
CY2022 | pmvc |
Class A Common Stock Subject To Possible Redemptionin Shares
ClassACommonStockSubjectToPossibleRedemptioninShares
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2021 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001807765 |